Managing IP’s statement regarding Talal Abu-Ghazaleh

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP’s statement regarding Talal Abu-Ghazaleh

ManagingIP_logo_2000px with border.png

Managing IP has been made aware of a television interview in which Talal Abu-Ghazaleh, the founder and chairman of law firm Abu-Ghazaleh Intellectual Property, can be seen making antisemitic comments about the Holocaust. In light of the serious and abhorrent nature of this hate speech, we are taking the following actions:

  • Placing all Managing IP awards won by Abu-Ghazaleh Intellectual Property under review 

  • Removing Abu-Ghazaleh Intellectual Property’s profile and accreditation from our rankings website, ipstars.com 

Our rankings and awards recognise the IP achievements and capabilities of firms and practitioners. Market reputation is one of the key pillars of our evaluation process. As the published comments clearly contravene this ethos, we believe this to be a necessary and justified course of action.

Managing IP has contacted Abu-Ghazaleh Intellectual Property for an official statement. In the meantime, we would like to distance ourselves from antisemitism and hate speech in any form.

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article